Streetbeat News

VAPO

Vapotherm Inc

https://vapotherm.com/

CEO

Joseph Army

Employees

334

Industry

Surgical and Medical Instrument Manufacturing

vapotherm develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. over 1 million patients have been successfully treated with vapotherm hi-vni technology, and the number is growing rapidly every day. we have an unrelenting commitment to improving patient lives, significant sales growth, a dynamic and exciting work environment, and a focus on hiring and developing the very best people in the medical device industry. now is a great time to join our growing team. vapotherm is a privately held company located in exeter, new hampshire. for more information, visit www.vapotherm.com.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Vapotherm (NYSE:VAPO) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-2.07. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $3.03, down 45.01% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:01 pm

The top five short squeeze candidates for the week include Ambrx Biopharma, Tempest Therapeutics, Torrid Holdings, Bitcoin Depot, and Vapotherm. These stocks have high short interest and steep borrowing costs, common traits that could lead to a short squeeze. Ambrx Biopharma and Tempest Therapeutics, both biotech stocks, top the list.

Portfolio Pulse from Chris Katje

October 31, 2023 | 2:21 pm

Vapotherm Inc (NASDAQ:VAPO) announced the results of a clinical trial showing its high flow humidified oxygen therapy to be more effective than standard oxygen therapy in treating children with acute severe asthma. The study found that fewer children treated with Vapotherm's therapy required escalation of treatment and met hospital discharge criteria sooner. Despite the positive trial results, VAPO shares are down 3.85%.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 8:16 pm

Several stocks are experiencing significant pre-market trading movements. Biophytis S.A. (BPTS) shares rose 31.5% following a partnership agreement with Skyepharma for the production of Sarconeos (BIO101). Avalo Therapeutics, Inc. (AVTX) shares gained 24% after the recent sale of its assets. Vapotherm, Inc. (VAPO) shares jumped 9.8% after announcing a clinical trial presentation. ESS Tech, Inc. (GWH) shares climbed 7.2% after Honeywell (HON) reported a strategic collaboration with the company. On the other hand, Rite Aid Corporation (RAD) shares fell 13.7% amid reports of potential bankruptcy.

Portfolio Pulse from Lisa Levin

September 25, 2023 | 12:31 pm

Vapotherm, Inc. (NYSE:VAPO) announced the results of a clinical trial showing that its high velocity therapy products reduced the need for escalation of therapy and hospital stay duration in children with acute severe asthma. The study was presented at the European Respiratory Society International Congress 2023.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 10:47 am

Insiders at Emeren Group Ltd (NYSE:SOL), Tecogen Inc. (OTC:TGEN), Full House Resorts, Inc. (NASDAQ:FLL), and Vapotherm, Inc. (NYSE:VAPO) have recently acquired shares in their respective companies. Emeren Group and Vapotherm posted positive Q2 results, while Tecogen reported a net loss and Full House Resorts posted a loss for the same period.

Portfolio Pulse from Lisa Levin

September 12, 2023 | 5:58 pm

The article lists the top five short squeeze candidates for the week, including Getty Images Holdings, Alset Capital Acquisition Corp, Bitcoin Depot, VistaGen Therapeutics, and Blue Apron Holdings. It also mentions five other stocks to watch that are rising on the charts with significant short percentages or borrowing costs, including Jupiter Wellness, Genius Group Limited, Bullfrog AI Holdings, AirSculpt Technologies, and Vapotherm Inc.

Portfolio Pulse from Chris Katje

September 11, 2023 | 2:52 pm

Insiders at OPKO Health, Vapotherm, and MarketWise have recently purchased shares in their respective companies. OPKO Health's CEO and Chairman acquired 75,000 shares at an average price of $1.75, following better-than-expected quarterly results. Vapotherm's President and CEO bought 300,000 shares at an average price of $0.40 after the company posted a narrower-than-expected Q2 loss. MarketWise's Director and CEO purchased a total of 25,800 shares at an average price of $1.71, despite weaker-than-expected quarterly sales.

Portfolio Pulse from Lisa Levin

August 16, 2023 | 1:08 pm

Vapotherm's CEO has purchased 300,000 shares of the company at $0.40 per share, according to a Form4 filing.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 6:30 pm

Vapotherm (NYSE:VAPO) reported Q2 earnings per share of $(0.29), beating the analyst consensus estimate of $(0.34) by 14.71%. However, the company's quarterly sales of $16.04 million missed the analyst consensus estimate of $17.00 million by 5.66%. Despite the miss, this represents a 23.64% increase over sales from the same period last year.

Portfolio Pulse from totan@benzinga.com

August 08, 2023 | 8:39 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.